EP3630819
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PROTEIN-LOSING ENTEROPATHY IN PATIENTS
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.5.2018:
11.10.2023:
18731616.1
:
20.5.2038
:
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PROTEIN-LOSING ENTEROPATHY IN PATIENTS
21.5.2018
11.10.2023
:
Alexion Pharmaceuticals, Inc.:
121 Seaport Boulevard, Boston, MA 02210, US
:
ADIV, Orly, Eshach:
3030000 Atlit, IL
:
BEDROSIAN, Camille:
Woodbridge CT 06525, US
:
FELDMAN, Hagit, Baris:
Boston MA 02210, US
:
KUROLAP, Alina:
3249516 Haifa, IL
:
MCKNIGHT, Susan, Faas:
Old Lyme CT 06371, US
:
201762509576 P:
22.5.2017:
US
:
US2018033678:
21.5.2018
:
C07K 16/18, C07K 16/40, A61K 39/00, C12Q 1/6883, G01N 33/68, A61P 1/00, A61P 3/00, A61P 7/00, A61P 9/00, A61P 37/00, G01N 33/574